Part 250 — Special Requirements for Specific Human Drugs
Current through Sep 8, 2026
Authority: 21 U.S.C. 321, 336, 342, 352, 353, 355, 361(a), 362(a) and (c), 371, 375(b).
Source: 40 FR 14033, Mar. 27, 1975, unless otherwise noted.
Sections
- § 250.11 Thyroid-containing drug preparations intended for treatment of obesity in humans.
- § 250.12 Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.
- § 250.100 Amyl nitrite inhalant as a prescription drug for human use.
- § 250.101 Amphetamine and methamphetamine inhalers regarded as prescription drugs.
- § 250.102 Drug preparations intended for human use containing certain “coronary vasodilators”.
- §§ 250.103-250.104 [Reserved]
- § 250.105 Gelsemium-containing preparations regarded as prescription drugs.
- §§ 250.106-250.107 [Reserved]
- § 250.108 Potassium permanganate preparations as prescription drugs.
- § 250.201 Preparations for the treatment of pernicious anemia.
- § 250.250 Hexachlorophene, as a component of drug and cosmetic products.